Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
about
Liposome-based drug delivery in breast cancer treatmentMetabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic AgentsMultifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cellsAge-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignanciesReceptor induction and targeted drug delivery: a new antileukaemia strategy.Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancerLiposomes as targeted drug delivery systems in the treatment of breast cancer.A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancerA phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.Liposomal doxorubicin in breast cancer.Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.New doxorubicin nanoparticles engineered from calcium-crosslinked carbomer and a microemulsion precursor.A simple home-based self-monitoring tool for early detection of hand-foot syndrome in cancer patients.
P2860
Q24802484-768E6096-8015-4BA0-88FA-94C1BAEFEF14Q26740567-0364513D-29C9-4CF9-B900-BB9D8ABBADB0Q30405605-105A261A-FCB4-44C2-93D3-6B7901300688Q33398947-565CA036-F743-4FE9-8F35-525ADC020AD0Q35164785-F0263F40-569B-4419-991E-5CDD593E8C17Q36508067-172C2B72-6CB3-4EB1-8D80-156951B7F456Q36554124-D0045FBF-7740-4AF2-8490-6F89B1EEA17EQ36624187-BB5476B9-AFEC-4FC2-A2C7-CF2F9E2E0600Q36644450-8ECB74C7-01A1-4F25-9A99-873D7A487DF0Q37355919-E923D033-6DC5-4A40-879A-8A9378A95A36Q37608442-508B798E-1319-4065-B8CD-CA1609AB75E6Q44202175-D44EA475-0810-4D22-809F-75A0CC45A582Q44439083-91C7749F-80BA-480F-8DE1-917484DBA6A2Q51158697-72F3D5A3-3D18-4E68-AE6C-D0759403EBF7Q54718288-BA062219-2AF1-46B7-B692-A483D4783E49
P2860
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Phase I study of stealth lipos ...... with metastatic breast cancer.
@ast
Phase I study of stealth lipos ...... with metastatic breast cancer.
@en
Phase I study of stealth lipos ...... with metastatic breast cancer.
@nl
type
label
Phase I study of stealth lipos ...... with metastatic breast cancer.
@ast
Phase I study of stealth lipos ...... with metastatic breast cancer.
@en
Phase I study of stealth lipos ...... with metastatic breast cancer.
@nl
prefLabel
Phase I study of stealth lipos ...... with metastatic breast cancer.
@ast
Phase I study of stealth lipos ...... with metastatic breast cancer.
@en
Phase I study of stealth lipos ...... with metastatic breast cancer.
@nl
P2093
P1476
Phase I study of stealth lipos ...... with metastatic breast cancer.
@en
P2093
F J Esteva
G N Hortobagyi
J L Murray
L Syrewicz
M M Rosales
R L Theriault
P304
P356
10.1200/JCO.2001.19.6.1716
P407
P577
2001-03-01T00:00:00Z